Lee Shin Ae, Kim Jin Kyu, Jo Dae Sun, Kim Sun Jun
Department of Pediatrics, Chonbuk National University Medical School, Jeonju, Korea.
Research Institute of Clinical Medicine, Chonbuk National University Medical School, Jeonju, Korea.
Infect Chemother. 2017 Dec;49(4):262-267. doi: 10.3947/ic.2017.49.4.262.
This study aimed to evaluate the efficacy of combined vancomycin and steroid therapy for the treatment of culture-proven bacterial meningitis in pediatric patients.
We identified a total of 86 pediatric patients with culture-positive cerebrospinal fluid who were treated at our facility between 2005 and 2015. Ten of these patients (5 boys and 5 girls) received first-line treatment with vancomycin as the initial form of therapy. All cultured bacteria were sensitive to vancomycin. We retrospectively analyzed these cases to examine the relationship between concomitant steroid dosage and antibiotic treatment effectiveness.
Nine of the 10 patients included in our analysis received steroid treatment. Of these, 3 received high-dose steroid therapy and 6 received low-dose steroid therapy. Five patients did not respond to vancomycin, including all 3 patients in the high-dose steroid group and 2 patients in the low-dose steroid group. Our analysis confirmed that the response rate to vancomycin treatment was significantly reduced in accordance with steroid dosage (P = 0.035). Patients who did not to respond to vancomycin with concomitant high-dose steroid administration improved clinically after the substitution of vancomycin with teicoplanin.
The use of steroids, especially in high doses, may impair the effectiveness of vancomycin for treating bacterial meningitis in pediatric patients. Physicians should be cautious when administering concomitant steroid therapy and should carefully monitor the steroid dosage.
本研究旨在评估万古霉素与类固醇联合治疗对确诊为细菌性脑膜炎的儿科患者的疗效。
我们确定了2005年至2015年间在我们机构接受治疗的86例脑脊液培养呈阳性的儿科患者。其中10例患者(5名男孩和5名女孩)接受了以万古霉素作为初始治疗形式的一线治疗。所有培养出的细菌对万古霉素敏感。我们对这些病例进行回顾性分析,以研究类固醇剂量与抗生素治疗效果之间的关系。
我们分析的10例患者中有9例接受了类固醇治疗。其中,3例接受高剂量类固醇治疗,6例接受低剂量类固醇治疗。5例患者对万古霉素无反应,包括高剂量类固醇组的所有3例患者和低剂量类固醇组的2例患者。我们的分析证实,万古霉素治疗的反应率随着类固醇剂量的增加而显著降低(P = 0.035)。在将万古霉素替换为替考拉宁后,同时接受高剂量类固醇治疗且对万古霉素无反应的患者临床症状有所改善。
使用类固醇,尤其是高剂量使用,可能会削弱万古霉素治疗儿科患者细菌性脑膜炎的有效性。医生在同时给予类固醇治疗时应谨慎,并应仔细监测类固醇剂量。